Roche News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

29.04.21	FDA Panel Votes To Keep Accelerated Approval For Roche's Tecentriq In Metastatic Bladder Cancer (RTTNews)
28.04.21	Roche Unveils Five New Ways To Use Cardiac Biomarkers For Better Diagnosis (RTTNews)
23.04.21	AbbVie Announces Positive CHMP Opinion For VENCLYXTO In Acute Myeloid Leukemia (RTTNews)
23.04.21	Roche's VENTANA MMR RxDx Panel Gets FDA Approval For Endometrial Cancer (RTTNews)
22.04.21	Roche Plans To Complete GenMark Acquisition Later Thursday (RTTNews)
21.04.21	Roche Stock Up On Higher Q1 Sales At Constant Rates; Backs FY21 Outlook (RTTNews)
21.04.21	Roche Q1 Sales Edges Down On Weak Pharma Sales; Backs FY21 Outlook - Quick Facts (RTTNews)
16.04.21	Genentech : Ocrevus Data Reinforce Benefit On Slowing Disease Progression In Multiple Sclerosis (RTTNews)
15.04.21	Roche : Evrysdi Continues To Improve Motor Function And Survival In Infants With Type 1 SMA (RTTNews)
13.04.21	FDA Approves Roche's Xolair Prefilled Syringe For Self-Injection Across All Indications (RTTNews)
08.04.21	Genentech To Present Data For Medicines For Treatment Of Neurological Disorders (RTTNews)
07.04.21	Roche Launches Elecsys Anti-p53 Immunoassay To Diagnose Several Prevalent Cancers (RTTNews)
06.04.21	Moleculin Biotech Engages IQVIA To Manage Potential COVID-19 Clinical Trial (RTTNews)
31.03.21	Roche Unveils Elecsys EBV Immunoassay Panel To Improve EBV Infection Staging (RTTNews)
30.03.21	PTC Therapeutics : EC Approves Evrysdi To Treat Spinal Muscular Atrophy (RTTNews)
29.03.21	Millendo To Merge With Tempest Therapeutics In An All-Stock Transaction (RTTNews)
27.03.21	Biotech Stocks Facing FDA Decision In April 2021 (RTTNews)
26.03.21	Roche Begins Tender Offer For GenMark Diagnostics For $24.05/shr In Cash (RTTNews)
23.03.21	Roche To Release Eight New High Throughput Configurations For Cobas Pro Integrated Solutions (RTTNews)
23.03.21	AZN's COVID-19 Jab Shows 79% Efficacy, ZEAL Wins FDA Approval, AdComm To Review Osteoarthritis Drug (RTTNews)
22.03.21	Roche, Genentech: Tecentriq Study Meets Primary Endpoint At Interim Analysis In Early Lung Cancer (RTTNews)
19.03.21	Genentech Recalls Prescription Drug Evrysdi (RTTNews)
17.03.21	Roche Launches Cobas Pure Integrated Solutions Analyser To Simplify Operations In Small Labs (RTTNews)
16.03.21	Roche Shareholders Approve All Proposals At AGM - Quick Facts (RTTNews)
16.03.21	Roche Launches Cobas SARS-CoV-2 Variant Set 1 Test To Detect SARS-CoV-2 Mutations (RTTNews)
16.03.21	Genentech : Data On Evrysdi Shows Improvement Of Motor Function In Spinal Muscular Atrophy Patients (RTTNews)
15.03.21	Roche To Buy GenMark Diagnostics In $1.8 Bln Cash Deal - Quick Facts (RTTNews)
11.03.21	Roche: REMDACTA Trial Fails To Meet Endpoints In Patients With Severe COVID-19 Pneumonia (RTTNews)
09.03.21	Roche : FDA Oks Ventana Assay To Identify Lung Cancer Patients Eligible For Treatment With LORBRENA (RTTNews)
08.03.21	Genentech Withdraws US Indication For Tecentriq In Prior-Platinum Treated Metastatic Bladder Cancer (RTTNews)
05.03.21	Roche: FDA Approves Actemra/RoActemra For Systemic Sclerosis-associated Interstitial Lung Disease (RTTNews)
26.02.21	Roche : CHMP Opinion Supports Use Of Casirivimab-imdevimab Antibody Cocktail For COVID Treatment (RTTNews)
25.02.21	Roche Reports Results From Evrysdi Study In Infants With Type 1 Spinal Muscular Atrophy (RTTNews)
12.02.21	Genentech's Faricimab Data Show Promise Of New Treatment For Two Common Causes Of Blindness (RTTNews)
08.02.21	Humana, Roche Agree To Pay $12.5 Mln To Settle False Claims (RTTNews)
08.02.21	Roche : FDA Grants Breakthrough Device Designation To Elecsys GDF-15 Assay (RTTNews)
04.02.21	Roche FY20 Profit Rises, Sales Down; Proposes Dividend; Sees Growth In FY21 Core EPS, Sales At CER (RTTNews)
27.01.21	Regeneron: Researchers Confirm Ability Of REGEN-COV To Neutralize SARS-CoV-2 Variants (RTTNews)
25.01.21	Genentech's Faricimab Meets Primary Endpoint In Late-stage Studies On Neovascular AMD (RTTNews)
21.01.21	FDA Grants Priority Review To Genentech' Esbriet For Unclassifiable Interstitial Lung Disease (RTTNews)
13.01.21	Roche : US To Purchase Addl Doses Of Antibody Cocktail For Use In Non-hospitalised COVID-19 Patients (RTTNews)
12.01.21	Roche: Updated Data Confirms Tecentriq With Avastin Substantially Improves Overall Survival In HCC (RTTNews)
11.01.21	European Commission Approves Roche's Xofluza For Treatment Of Influenza (RTTNews)
05.01.21	Roche:Tiragolumab-Tecentriq Gets FDA Breakthrough Therapy Designation For Non-small Cell Lung Cancer (RTTNews)
23.12.20	Roche: EU Approves Phesgo To Treat HER2-positive Breast Cancer - Quick Facts (RTTNews)
05.03.19	Roche Annual General Meeting 2019 (GlobeNewswire)
10.10.18	OCREVUS (Ocrelizumab) fünf-Jahresdaten zeigen, dass ein früher Therapiebeginn bei schubförmiger und primär progredienter multipler Sklerose das Fortschreiten der Erkrankung reduziert (GlobeNewswire)
27.05.10	New York Portfolio Clearing Names Ira Krulik as COO, Kevin Murray as Director of Business Operations (Businesswire)
31.03.10	Non-Invasive Real-time Monitoring of Membrane Cholesterol Dynamics in Human Keratinocytes with Roche’s xCELLigence System (Businesswire)
25.02.10	imaGenes GmbH Adds Certification of Roche NimbleGen DNA Methylation Analysis to Service Portfolio (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

25.06.24		Roche kann EU-Zulassung für Multiple-Sklerose-Mittel an Land ziehen - Aktie sinkt dennoch
10.06.24		Roche-Aktie dennoch tiefer: EU-Kommission lässt Lungenkrebsmedikament Alecensa zu
21.05.24		Roche-Aktie schwächer: Roche-Übernahme von LumiraDx in prüfung - Inavolisib erhält "Breakthrough Therapy"-Status
11.12.23		Roche-Aktie etwas fester: Roche legt Studiendaten zu Kadcyla, Hemlibra, Columvi und Lunsumio vor
02.02.23		Roche-Aktie schwächer: Roche erreicht 2022 Prognose - Umsatz- und Gewinnrückgang im neuen Jahr erwartet
27.12.22		Roche-Aktie leichter: FDA lässt Roches Lymphom-Behandlung Lunsumio zu
16.09.22		Roche-Aktie gewinnt: Moody's hebt Bonitätseinstufung für Roche an
25.04.22		Roche-Aktie leichter: Umsatz übertrifft Erwartungen

25.06.24

Roche kann EU-Zulassung für Multiple-Sklerose-Mittel an Land ziehen - Aktie sinkt dennoch

10.06.24

Roche-Aktie dennoch tiefer: EU-Kommission lässt Lungenkrebsmedikament Alecensa zu

21.05.24

Roche-Aktie schwächer: Roche-Übernahme von LumiraDx in prüfung - Inavolisib erhält "Breakthrough Therapy"-Status

11.12.23

Roche-Aktie etwas fester: Roche legt Studiendaten zu Kadcyla, Hemlibra, Columvi und Lunsumio vor

02.02.23

Roche-Aktie schwächer: Roche erreicht 2022 Prognose - Umsatz- und Gewinnrückgang im neuen Jahr erwartet

27.12.22

Roche-Aktie leichter: FDA lässt Roches Lymphom-Behandlung Lunsumio zu